Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) today announced its financial results for the three months ended December 31, 2025 ("Q3 FY2026"). All financial ...

Q4 2025 Management View CEO Jonathan Steinberg highlighted that "organic growth and operating discipline working in tandem ...

Accenture demonstrates durable competitive advantages, steady growth, and resilient operating performance, but future returns ...

Learn what financial instruments are, explore major types and asset classes, and understand how they work in investing, trading, and portfolio construction.

In 2025, New York enacted laws creating a new legal framework—UCC Article 12—for digital assets like cryptocurrencies and NFTs. It focuses on control rather than possession, clarifies transfer and ...

The advocates estimate their surtax, with a lower trigger point, would apply to fewer tax filers, 2,300, than McKee's which was not immediately explained, while the proposed "wealth tax" would apply ...

Bank of New York Mellon Corp. has launched a tokenized deposit service that allows clients to transfer funds using blockchain rails, becoming the latest major global bank to push deeper into digital ...

As digital assets continue to see increased interest and adoption, many market participants are looking for the same things they expect from traditional asset classes: transparency, governance, and ...

Americans filed hundreds of thousands of bankruptcy petitions over the past year, with Chapter 7 representing a large percentage of those cases. That makes sense considering that Chapter 7 is ...

Switzerland announced Monday that it has frozen assets held in the country tied to Venezuelan President Nicolás Maduro and his associates following the U.S. capture of the leader in Caracas. "On 5 ...

Money-market funds pulled in $935 billion in new assets last year, pushing total assets above $8 trillion and surpassing their haul in 2024, according to new research from Morgan Stanley. The low-risk ...

(RTTNews) - Sanofi (SNY, SAN.PA) announced that the U.S. Food and Drug Administration has issued a complete response letter (CRL) for the new drug application of tolebrutinib to treat non-relapsing ...